Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-027986
Filing Date
2022-11-03
Accepted
2022-11-03 07:51:06
Documents
84
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lnth-20220930.htm   iXBRL 10-Q 1741816
2 EX-31.1 lnth10q-093022ex311.htm EX-31.1 11783
3 EX-31.2 lnth10q-093022ex312.htm EX-31.2 11669
4 EX-32.1 lnth10q-093022ex321.htm EX-32.1 9866
  Complete submission text file 0001628280-22-027986.txt   7881137

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lnth-20220930.xsd EX-101.SCH 47473
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lnth-20220930_cal.xml EX-101.CAL 98694
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lnth-20220930_def.xml EX-101.DEF 175730
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lnth-20220930_lab.xml EX-101.LAB 591817
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lnth-20220930_pre.xml EX-101.PRE 369626
78 EXTRACTED XBRL INSTANCE DOCUMENT lnth-20220930_htm.xml XML 1551749
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Filer) CIK: 0001521036 (see all company filings)

EIN.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36569 | Film No.: 221356297
SIC: 2835 In Vitro & In Vivo Diagnostic Substances